Dextromethorphan and guaifenesin use really should be monitored very carefully in people with "inadequate metabolizer" CYP2D6 enzyme levels and clients that are sedated. This mixture medication contains a huge median harmful dose (TD50) to median efficient dose (ED50) ratio (or therapeutic index) in these clients. Delsym has a complete line https://chemicalglobe.com/